M Usami

413 total citations
28 papers, 308 citations indexed

About

M Usami is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, M Usami has authored 28 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in M Usami's work include Prostate Cancer Treatment and Research (7 papers), Kawasaki Disease and Coronary Complications (6 papers) and Cancer, Lipids, and Metabolism (5 papers). M Usami is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Kawasaki Disease and Coronary Complications (6 papers) and Cancer, Lipids, and Metabolism (5 papers). M Usami collaborates with scholars based in Japan. M Usami's co-authors include Naruhiko Sahara, Nobuhiro Suzuki, Nobuyuki Nukina, Hidehiro Mizusawa, Akira Tamaoka, S Shoji, Asano Odaka, Ichiro Kanazawa, Natsumi Inoue and Masaki Shimizu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

M Usami

28 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Usami Japan 9 155 123 57 54 41 28 308
Neil J. Korman United States 6 143 0.9× 36 0.3× 19 0.3× 37 0.7× 16 0.4× 8 459
Geneviève Beaurain France 8 36 0.2× 93 0.8× 53 0.9× 22 0.4× 19 0.5× 9 349
Tetsuya Abe Japan 13 65 0.4× 107 0.9× 30 0.5× 11 0.2× 70 1.7× 31 371
Linda M. Kapp United States 12 51 0.3× 73 0.6× 56 1.0× 87 1.6× 15 0.4× 20 395
Takashi Akasaki Japan 9 115 0.7× 139 1.1× 33 0.6× 9 0.2× 122 3.0× 13 453
Leena Kytömäki Finland 8 36 0.2× 146 1.2× 28 0.5× 27 0.5× 12 0.3× 13 301
Isabel Morales-Ivorra Spain 6 39 0.3× 123 1.0× 16 0.3× 46 0.9× 11 0.3× 16 289
Geneviève Lavallée Canada 4 44 0.3× 101 0.8× 29 0.5× 17 0.3× 10 0.2× 6 271
Åsa Betten Sweden 6 28 0.2× 120 1.0× 57 1.0× 24 0.4× 13 0.3× 7 374
Shun Cui China 7 96 0.6× 155 1.3× 15 0.3× 13 0.2× 18 0.4× 8 293

Countries citing papers authored by M Usami

Since Specialization
Citations

This map shows the geographic impact of M Usami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Usami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Usami more than expected).

Fields of papers citing papers by M Usami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Usami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Usami. The network helps show where M Usami may publish in the future.

Co-authorship network of co-authors of M Usami

This figure shows the co-authorship network connecting the top 25 collaborators of M Usami. A scholar is included among the top collaborators of M Usami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Usami. M Usami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yokoyama, Tadafumi, et al.. (2023). CD169 expression on monocytes as a marker for assessing type I interferon status in pediatric inflammatory diseases. Clinical Immunology. 250. 109329–109329. 10 indexed citations
2.
Usami, M, Ichiro Takeuchi, Hiroki Fujikawa, et al.. (2022). Clinical features of very early-onset inflammatory bowel disease in Japan: a retrospective single-center study. Intestinal Research. 20(4). 475–481. 6 indexed citations
3.
Shimizu, Hirotaka, Takahiro Kudo, Tomoko Hara, et al.. (2022). Both fecal calprotectin and fecal immunochemical tests are useful in children with inflammatory bowel disease. Journal of Gastroenterology. 57(5). 344–356. 9 indexed citations
4.
Takeuchi, Ichiro, et al.. (2021). Features and Outcomes of Children with Ulcerative Colitis who Undergo a Diagnostic Change: A Single-Center Experience. Pediatric Gastroenterology Hepatology & Nutrition. 24(4). 357–357. 1 indexed citations
5.
Mizuta, Mao, Masaki Shimizu, M Usami, et al.. (2020). Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children. Lara D. Veeken. 60(1). 231–238. 22 indexed citations
6.
Shimizu, Masaki, Shuya Kaneko, M Usami, et al.. (2019). Cytokine profile of macrophage activation syndrome associated with Kawasaki disease. Cytokine. 119. 52–56. 33 indexed citations
7.
Usami, M, Masaki Shimizu, Mao Mizuta, et al.. (2019). Extensive serum biomarker analysis in patients with macrophage activation syndrome associated with systemic lupus erythematosus. Clinical Immunology. 208. 108255–108255. 14 indexed citations
8.
9.
Naito, Seiji, Takashi Deguchi, Mikio Namiki, et al.. (2004). Addition of bicalutamide 80 mg to LHRH-agonist monotherapy in patients with advanced prostate cancer: Impact on quality of life. Journal of Clinical Oncology. 22(14_suppl). 4703–4703. 3 indexed citations
10.
Maruyama, Kei, M Usami, Fuyuki Kametani, et al.. (2000). Molecular interactions between presenilin and calpain: inhibition of m-calpain protease activity by presenilin-1, 2 and cleavage of presenilin-1 by m-, mu-calpain.. International Journal of Molecular Medicine. 5(3). 269–73. 13 indexed citations
11.
Maeda, Osamu, Toshiaki Kinouchi, Norio Meguro, et al.. (1998). Adjunctive Value of Cell Proliferation but Not of Apoptosis to Interpret Pathologic Effects on Prostatic Cancer after Neoadjuvant Endocrine Therapy. Japanese Journal of Clinical Oncology. 28(4). 262–266. 3 indexed citations
12.
Okochi, Masayasu, Naruhiko Sahara, Fuyuki Kametani, et al.. (1998). Presenilin 1 Cleavage is a Universal Event in Human Organs. Neurobiology of Aging. 19(1). S3–S10. 7 indexed citations
13.
Meguro, Norio, Yoshitsugu Nakamura, Shinji Saiki, et al.. (1997). Coexistence of renal cell carcinoma and renal angiomyolipoma developing in a kidney: a case report.. PubMed. 43(2). 131–5. 8 indexed citations
14.
Maeda, Osamu, Norio Meguro, Shinji Saiki, et al.. (1996). [Neoadjuvant endocrine therapy in patients with locally advanced prostate cancer].. PubMed. 42(10). 821–7. 1 indexed citations
15.
Sahara, Naruhiko, Yuichi Yahagi, Masayasu Okochi, et al.. (1996). 729 Identification and characterization of presenilin I-467, I-463 and I-374. Neurobiology of Aging. 17(4). S181–S181. 2 indexed citations
16.
Maeda, Osamu, Norio Meguro, Shinji Saiki, et al.. (1995). Preoperative Endocrine Therapy in Patients with Locally Advanced Prostate Cancer. Japanese Journal of Clinical Oncology. 25(4). 135–9. 2 indexed citations
17.
Tamaoka, Akira, Asano Odaka, M Usami, et al.. (1994). APP717 missense mutation affects the ratio of amyloid beta protein species (A beta 1-42/43 and a beta 1-40) in familial Alzheimer's disease brain. Journal of Biological Chemistry. 269(52). 32721–32724. 143 indexed citations
18.
Maeda, Osamu, Shinji Saiki, Toshiro Kinouchi, et al.. (1991). [Clinical study of incidental prostatic carcinoma].. PubMed. 37(2). 135–9. 3 indexed citations
19.
Koh, E., et al.. (1989). [A case of primary ureteral squamous cell carcinoma associated with calculus].. PubMed. 35(1). 105–9. 2 indexed citations
20.
Kadota, Ken, et al.. (1983). Separation of Synaptic Vesicles from Bovine Cerebral Cortex. Journal of Electron Microscopy. 32(3). 210–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neil J. Korman Breakdown of academic impact, for papers by Geneviève Beaurain Breakdown of academic impact, for papers by Tetsuya Abe Breakdown of academic impact, for papers by Linda M. Kapp Breakdown of academic impact, for papers by Takashi Akasaki Breakdown of academic impact, for papers by Leena Kytömäki Breakdown of academic impact, for papers by Isabel Morales-Ivorra Breakdown of academic impact, for papers by Geneviève Lavallée Breakdown of academic impact, for papers by Åsa Betten Breakdown of academic impact, for papers by Shun Cui
Rankless by CCL
2026